Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 59651-847

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 59651-847). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label.principal Display Panel (100 mg (100 Tablets Bottle))

Package Label.principal Display Panel (100 mg (100 Tablets Bottle))
Label for Bupropion Hydrochloride Extended-Release Tablets USP (SR) 100 mg by Aurobindo Pharma Limited. The label includes dosage strength, NDC 59651-846-01, a green round tablet marked with "100", packaging size of 100 tablets, and storage instructions. It mentions the product is for twice-a-day use after initial titration, with a warning against use with ZYBAN or other bupropion hydrochloride products. Distributed by Aurobindo Pharma USA, Inc., made in India, with a barcode and coding area indicated.*
FDA Label Image

Package Label.principal Display Panel (150 mg (100 Tablets Bottle))

Package Label.principal Display Panel (150 mg (100 Tablets Bottle))
Label for Bupropion Hydrochloride Extended-Release Tablets USP (SR) 150 mg by Aurobindo Pharma Limited. The label includes dosing warnings, dispensing instructions, and storage conditions. It features a green, round tablet embossed with "150" and states package contains 100 tablets. Distributed by Aurobindo Pharma USA, Inc., made in India.*
FDA Label Image

Package Label.principal Display Panel (200 mg (100 Tablets Bottle))

Package Label.principal Display Panel (200 mg (100 Tablets Bottle))
Label for Bupropion Hydrochloride Extended-Release Tablets, USP (SR) 200 mg, film-coated, oral tablets. The label indicates a package quantity of 100 tablets and features warnings about concurrent use with ZYBAN or other bupropion hydrochloride medicines. Distributed by Aurobindo Pharma USA, Inc., the label includes storage and handling instructions and a barcode on the right side.*
FDA Label Image

Str (Buprop Str)

Str (Buprop Str)
Chemical structure diagram of bupropion hydrochloride, showing its molecular framework including a chlorophenyl group and tert-butyl ketone moiety with an attached hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.